Skip to main content
Caplight Logo









ArcomedLab

ArcomedLab

Private
Miami, FloridaHealthcare & Life Scienceshttps://arcomedlab.com/

Last Round

VC Round

Jan 21, 2025

Total Funding Raised

$80,000

Company Overview

ArcomedLab operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a VC Round in January 2025.

ArcomedLab is a medical technology company that specializes in the design and manufacturing of custom 3D-printed synthetic bone implants for cranial and maxillofacial reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ArcomedLab Comparables

Compare ArcomedLab with similar companies based on industry and business-model similarity.

ArcomedLab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xilloc Medical B.V.
81%
Kelyniam Global, Inc.
80%
LUCID Implants
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ArcomedLab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 21, 2025
AcceleratorJun 13, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ilan Rosenberg

CEO - Founder arcomedlab

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    Monthly visitors grew 581% MoM, reaching 429.

  • Jan 21, 2025

    $2.5M round led by The Ganesha Lab.

Book a demo to see all signals

For institutional investors. Book with your work email.

ArcomedLab Filings

Explore SEC and related filing metadata, where available.

ArcomedLab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ArcomedLab's valuation, stock price, and market status.

Is ArcomedLab a public or private company?

ArcomedLab is a private company.

What is the current stock price of ArcomedLab?

ArcomedLab is a private company, so its shares have no public market price. Caplight tracks ArcomedLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ArcomedLab worth (valuation)?

Valuation information for ArcomedLab is not publicly available.

Can I buy ArcomedLab stock?

ArcomedLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ArcomedLab's last funding round?

ArcomedLab's most recent funding round was VC Round on January 21, 2025.

Who are the main investors in ArcomedLab?

Investor information for ArcomedLab is not publicly disclosed.

Will ArcomedLab IPO soon?

No public IPO plans have been announced for ArcomedLab.

How can I track ArcomedLab secondary market activity?

Caplight tracks bids, offers, and trades in ArcomedLab's shares on secondary markets.

Firmographic Details

HeadquartersMiami, Florida
Employee Range12
Year Founded2018
Last FundingJan 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?